The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be held on March 2, 2011. The proposed agenda is as follows:
Morning Session
• Greetings and Overview (10:00 - 10:15 am EDT): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
• Protest (10:15 - 11:15 am): Bennett Celsa, QAS, TC1600
• Break (11:15 - 11:30 am)
• Help the USPTO improve the MPEP using an Online Collaboration Tool (11:30 am - 12:00 pm): Robert Clarke, Office of Patent Legal Administration
• PATI (12:00 - 12:20 pm): Terrel Morris, SIRA
• Lunch (12:20 – 1:30 pm)
Afternoon Session
• Current USPTO Initiatives (1:30 - 2:30 pm): Robert Stoll, Commissioner for Patents
• Break (2:30 - 2:45 pm)
• Microsoft v. i4i Ltd.: How potential changes in the evidentiary standard for an invalidity defense could affect patent prosecution and litigation (2:45 - 4:00 pm): Garth M. Dahlen, Ph.D., Esq., Birch, Stewart, Kolasch & Birch, LLP
• Closing Remarks/Discussion (4:00 - 4:15 pm): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Auditorium in Madison East, 600 Dulany Street, Alexandria, VA, or viewed online here (select the "enter as guest" option). The Patent Office asks that non-USPTO employees login using their e-mail addresses. Additional information regarding the BCP customer partnership meeting can be found here.
Comments